nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—hematopoietic system—hematologic cancer	0.0616	0.261	CbGeAlD
Tyloxapol—LPL—blood—hematologic cancer	0.0408	0.173	CbGeAlD
Tyloxapol—LPL—bone marrow—hematologic cancer	0.0395	0.167	CbGeAlD
Tyloxapol—LPL—lung—hematologic cancer	0.0358	0.152	CbGeAlD
Tyloxapol—LPL—testis—hematologic cancer	0.0338	0.143	CbGeAlD
Tyloxapol—LPL—lymph node—hematologic cancer	0.0245	0.104	CbGeAlD
Tyloxapol—LPL—Developmental Biology—MAPK14—hematologic cancer	0.000762	0.000997	CbGpPWpGaD
Tyloxapol—LPL—Disease—NUP214—hematologic cancer	0.000761	0.000996	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GNA13—hematologic cancer	0.000753	0.000986	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MET—hematologic cancer	0.00075	0.000982	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CDK4—hematologic cancer	0.00075	0.000982	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SPHK1—hematologic cancer	0.00075	0.000981	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTR—hematologic cancer	0.000746	0.000976	CbGpPWpGaD
Tyloxapol—LPL—Disease—XIAP—hematologic cancer	0.000746	0.000976	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TIAM1—hematologic cancer	0.000741	0.00097	CbGpPWpGaD
Tyloxapol—LPL—Disease—ENO2—hematologic cancer	0.000731	0.000957	CbGpPWpGaD
Tyloxapol—LPL—Disease—SMARCA4—hematologic cancer	0.000727	0.000951	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NOTCH1—hematologic cancer	0.000722	0.000945	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—UGT1A1—hematologic cancer	0.00072	0.000943	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JAK3—hematologic cancer	0.000719	0.000941	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC22A1—hematologic cancer	0.000701	0.000917	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CRABP1—hematologic cancer	0.000701	0.000917	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PTPN11—hematologic cancer	0.000694	0.000908	CbGpPWpGaD
Tyloxapol—LPL—Disease—SDC1—hematologic cancer	0.000693	0.000907	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL13—hematologic cancer	0.000689	0.000902	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCR7—hematologic cancer	0.000689	0.000902	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALOX5—hematologic cancer	0.000683	0.000894	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NCOR2—hematologic cancer	0.00068	0.00089	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CREB1—hematologic cancer	0.000672	0.00088	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL3RA—hematologic cancer	0.000671	0.000879	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CRKL—hematologic cancer	0.000671	0.000879	CbGpPWpGaD
Tyloxapol—LPL—Disease—LCK—hematologic cancer	0.000671	0.000879	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NUP98—hematologic cancer	0.000661	0.000865	CbGpPWpGaD
Tyloxapol—LPL—Disease—H3F3A—hematologic cancer	0.000658	0.000861	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—IL6R—hematologic cancer	0.000656	0.000858	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CREBBP—hematologic cancer	0.000655	0.000857	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RGS2—hematologic cancer	0.000648	0.000848	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NCOA3—hematologic cancer	0.000642	0.00084	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ADCY7—hematologic cancer	0.000642	0.00084	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TRIO—hematologic cancer	0.000641	0.000838	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CMA1—hematologic cancer	0.000641	0.000838	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TRH—hematologic cancer	0.000641	0.000838	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRKCZ—hematologic cancer	0.00064	0.000837	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NUP214—hematologic cancer	0.000637	0.000834	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	0.000631	0.000826	CbGpPWpGaD
Tyloxapol—LPL—Disease—CALR—hematologic cancer	0.000628	0.000823	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AGO2—hematologic cancer	0.000627	0.00082	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SPHK1—hematologic cancer	0.000627	0.00082	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MAP2K1—hematologic cancer	0.000625	0.000818	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTR—hematologic cancer	0.000624	0.000817	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCG2—hematologic cancer	0.000624	0.000817	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HDAC9—hematologic cancer	0.00062	0.000812	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LPAR1—hematologic cancer	0.00062	0.000812	CbGpPWpGaD
Tyloxapol—LPL—Disease—PARP1—hematologic cancer	0.000618	0.000809	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—H3F3B—hematologic cancer	0.000614	0.000804	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ENO2—hematologic cancer	0.000612	0.000802	CbGpPWpGaD
Tyloxapol—LPL—Disease—FBXW7—hematologic cancer	0.000608	0.000796	CbGpPWpGaD
Tyloxapol—LPL—Disease—HDAC2—hematologic cancer	0.000596	0.00078	CbGpPWpGaD
Tyloxapol—LPL—Disease—CXCR4—hematologic cancer	0.000596	0.00078	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—FGF2—hematologic cancer	0.000595	0.000778	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTT1—hematologic cancer	0.000594	0.000777	CbGpPWpGaD
Tyloxapol—LPL—Disease—CD44—hematologic cancer	0.000589	0.000771	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	0.000585	0.000766	CbGpPWpGaD
Tyloxapol—LPL—Disease—CBL—hematologic cancer	0.000581	0.00076	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SDC1—hematologic cancer	0.000581	0.00076	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CNR2—hematologic cancer	0.000571	0.000747	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDE4B—hematologic cancer	0.000571	0.000747	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—JAK2—hematologic cancer	0.00057	0.000746	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGF19—hematologic cancer	0.000566	0.000741	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RAC2—hematologic cancer	0.000562	0.000735	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DKK1—hematologic cancer	0.000557	0.000729	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	0.000555	0.000726	CbGpPWpGaD
Tyloxapol—LPL—Disease—HSP90AA1—hematologic cancer	0.000554	0.000725	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STAT5B—hematologic cancer	0.000553	0.000724	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	0.000547	0.000717	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADCY7—hematologic cancer	0.000537	0.000703	CbGpPWpGaD
Tyloxapol—LPL—Disease—STAT1—hematologic cancer	0.000534	0.000699	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	0.000524	0.000685	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—XIAP—hematologic cancer	0.000522	0.000683	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SH2B3—hematologic cancer	0.000509	0.000666	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SMARCA4—hematologic cancer	0.000509	0.000666	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GZMB—hematologic cancer	0.000506	0.000662	CbGpPWpGaD
Tyloxapol—LPL—Disease—GRB2—hematologic cancer	0.0005	0.000654	CbGpPWpGaD
Tyloxapol—LPL—Disease—PDGFA—hematologic cancer	0.000499	0.000653	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CTNNA1—hematologic cancer	0.000494	0.000646	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CD44—hematologic cancer	0.000494	0.000646	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NQO1—hematologic cancer	0.000494	0.000646	CbGpPWpGaD
Tyloxapol—LPL—Disease—KITLG—hematologic cancer	0.000492	0.000643	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EIF4EBP1—hematologic cancer	0.000491	0.000643	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HSPB1—hematologic cancer	0.000491	0.000643	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCL3—hematologic cancer	0.000491	0.000643	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTHLH—hematologic cancer	0.000485	0.000635	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SDC1—hematologic cancer	0.000485	0.000635	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	0.000483	0.000633	CbGpPWpGaD
Tyloxapol—LPL—Disease—STAT5A—hematologic cancer	0.00048	0.000629	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN2B—hematologic cancer	0.000476	0.000623	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTGER4—hematologic cancer	0.000473	0.000619	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LCK—hematologic cancer	0.00047	0.000615	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYCS—hematologic cancer	0.000467	0.000611	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HSP90AA1—hematologic cancer	0.000464	0.000607	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—H3F3A—hematologic cancer	0.000461	0.000603	CbGpPWpGaD
Tyloxapol—LPL—Disease—CD86—hematologic cancer	0.000461	0.000603	CbGpPWpGaD
Tyloxapol—LPL—Disease—HES1—hematologic cancer	0.000454	0.000595	CbGpPWpGaD
Tyloxapol—LPL—Disease—NCOR1—hematologic cancer	0.000452	0.000591	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKCZ—hematologic cancer	0.000448	0.000586	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGF1—hematologic cancer	0.000447	0.000585	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EP300—hematologic cancer	0.000446	0.000584	CbGpPWpGaD
Tyloxapol—LPL—Disease—FOXO1—hematologic cancer	0.00044	0.000576	CbGpPWpGaD
Tyloxapol—LPL—Disease—PDGFRB—hematologic cancer	0.000439	0.000575	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SRC—hematologic cancer	0.000434	0.000568	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PARP1—hematologic cancer	0.000433	0.000566	CbGpPWpGaD
Tyloxapol—LPL—Disease—PDGFRA—hematologic cancer	0.000433	0.000566	CbGpPWpGaD
Tyloxapol—LPL—Disease—JAK1—hematologic cancer	0.000431	0.000564	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRKCG—hematologic cancer	0.000431	0.000564	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FBXW7—hematologic cancer	0.000426	0.000557	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—VEGFA—hematologic cancer	0.000422	0.000553	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—STAT3—hematologic cancer	0.000418	0.000547	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	0.000418	0.000547	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HDAC2—hematologic cancer	0.000417	0.000546	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCR4—hematologic cancer	0.000417	0.000546	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NRAS—hematologic cancer	0.000417	0.000546	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTP1—hematologic cancer	0.000412	0.000539	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CBL—hematologic cancer	0.000407	0.000532	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL3—hematologic cancer	0.000402	0.000527	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MAPK3—hematologic cancer	0.0004	0.000523	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTHFR—hematologic cancer	0.000399	0.000523	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	0.000398	0.000521	CbGpPWpGaD
Tyloxapol—LPL—Disease—HLA-A—hematologic cancer	0.000398	0.000521	CbGpPWpGaD
Tyloxapol—LPL—Disease—TERT—hematologic cancer	0.000398	0.000521	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTPN1—hematologic cancer	0.000396	0.000518	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCB1—hematologic cancer	0.00039	0.00051	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RASGRP1—hematologic cancer	0.000389	0.00051	CbGpPWpGaD
Tyloxapol—LPL—Disease—PDGFB—hematologic cancer	0.000389	0.000509	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SYK—hematologic cancer	0.000388	0.000508	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HSP90AA1—hematologic cancer	0.000388	0.000508	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TGFB1—hematologic cancer	0.000388	0.000507	CbGpPWpGaD
Tyloxapol—LPL—Disease—TSC2—hematologic cancer	0.00038	0.000497	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTM1—hematologic cancer	0.000378	0.000495	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NCOR1—hematologic cancer	0.000378	0.000495	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STAT1—hematologic cancer	0.000374	0.00049	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGFR3—hematologic cancer	0.000365	0.000478	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TNF—hematologic cancer	0.000362	0.000474	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KRAS—hematologic cancer	0.000359	0.00047	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GRB2—hematologic cancer	0.00035	0.000458	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDGFA—hematologic cancer	0.000349	0.000457	CbGpPWpGaD
Tyloxapol—LPL—Disease—BAD—hematologic cancer	0.000346	0.000453	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KITLG—hematologic cancer	0.000344	0.000451	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOTCH1—hematologic cancer	0.000343	0.000449	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STAT5A—hematologic cancer	0.000336	0.00044	CbGpPWpGaD
Tyloxapol—LPL—Disease—CD80—hematologic cancer	0.000336	0.00044	CbGpPWpGaD
Tyloxapol—LPL—Disease—KIT—hematologic cancer	0.000335	0.000439	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTHFR—hematologic cancer	0.000334	0.000438	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN2B—hematologic cancer	0.000334	0.000437	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTPN11—hematologic cancer	0.00033	0.000431	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CD86—hematologic cancer	0.000323	0.000422	CbGpPWpGaD
Tyloxapol—LPL—Disease—CREB1—hematologic cancer	0.000319	0.000418	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HES1—hematologic cancer	0.000318	0.000416	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NCOR1—hematologic cancer	0.000316	0.000414	CbGpPWpGaD
Tyloxapol—LPL—Disease—BRAF—hematologic cancer	0.000315	0.000413	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGF1—hematologic cancer	0.000313	0.000409	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CSF2—hematologic cancer	0.000313	0.000409	CbGpPWpGaD
Tyloxapol—LPL—Disease—IL6R—hematologic cancer	0.000311	0.000408	CbGpPWpGaD
Tyloxapol—LPL—Disease—CREBBP—hematologic cancer	0.000311	0.000407	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FOXO1—hematologic cancer	0.000308	0.000404	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDGFRB—hematologic cancer	0.000308	0.000403	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HRAS—hematologic cancer	0.000305	0.0004	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDGFRA—hematologic cancer	0.000303	0.000397	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKCG—hematologic cancer	0.000302	0.000395	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JAK1—hematologic cancer	0.000302	0.000395	CbGpPWpGaD
Tyloxapol—LPL—Disease—MAP2K1—hematologic cancer	0.000297	0.000389	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CD—hematologic cancer	0.000295	0.000386	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	0.000295	0.000386	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—IL6—hematologic cancer	0.000292	0.000382	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGF2—hematologic cancer	0.000282	0.00037	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL2RA—hematologic cancer	0.000282	0.000369	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CG—hematologic cancer	0.000281	0.000368	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TERT—hematologic cancer	0.000279	0.000365	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3R1—hematologic cancer	0.000278	0.000364	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDGFB—hematologic cancer	0.000272	0.000356	CbGpPWpGaD
Tyloxapol—LPL—Disease—JAK2—hematologic cancer	0.000271	0.000354	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT1—hematologic cancer	0.00027	0.000353	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TSC2—hematologic cancer	0.000266	0.000348	CbGpPWpGaD
Tyloxapol—LPL—Disease—MDM2—hematologic cancer	0.000264	0.000346	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CREBBP—hematologic cancer	0.00026	0.000341	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CB—hematologic cancer	0.000257	0.000336	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTOR—hematologic cancer	0.000257	0.000336	CbGpPWpGaD
Tyloxapol—LPL—Disease—CD4—hematologic cancer	0.000257	0.000336	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGFR3—hematologic cancer	0.000256	0.000335	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK14—hematologic cancer	0.000253	0.000332	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ESR1—hematologic cancer	0.000248	0.000325	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CD—hematologic cancer	0.000247	0.000323	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FN1—hematologic cancer	0.000245	0.000321	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALB—hematologic cancer	0.000244	0.000319	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NFKBIA—hematologic cancer	0.000243	0.000317	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BAD—hematologic cancer	0.000243	0.000317	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN1B—hematologic cancer	0.000241	0.000316	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH1—hematologic cancer	0.00024	0.000314	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CD80—hematologic cancer	0.000235	0.000308	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CG—hematologic cancer	0.000235	0.000307	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KIT—hematologic cancer	0.000235	0.000307	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3R1—hematologic cancer	0.000233	0.000305	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTPN11—hematologic cancer	0.000231	0.000302	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CREB1—hematologic cancer	0.000224	0.000293	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN1A—hematologic cancer	0.000223	0.000291	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTEN—hematologic cancer	0.000222	0.000291	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BRAF—hematologic cancer	0.000221	0.000289	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCL2—hematologic cancer	0.000219	0.000286	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL6R—hematologic cancer	0.000218	0.000285	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CREBBP—hematologic cancer	0.000218	0.000285	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CB—hematologic cancer	0.000215	0.000282	CbGpPWpGaD
Tyloxapol—LPL—Disease—EP300—hematologic cancer	0.000212	0.000277	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAP2K1—hematologic cancer	0.000208	0.000272	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CD—hematologic cancer	0.000206	0.00027	CbGpPWpGaD
Tyloxapol—LPL—Disease—SRC—hematologic cancer	0.000206	0.00027	CbGpPWpGaD
Tyloxapol—LPL—Disease—STAT3—hematologic cancer	0.000199	0.00026	CbGpPWpGaD
Tyloxapol—LPL—Disease—NRAS—hematologic cancer	0.000198	0.000259	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGF2—hematologic cancer	0.000198	0.000259	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3R1—hematologic cancer	0.000195	0.000255	CbGpPWpGaD
Tyloxapol—LPL—Disease—MAPK3—hematologic cancer	0.00019	0.000248	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JAK2—hematologic cancer	0.00019	0.000248	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTEN—hematologic cancer	0.000186	0.000243	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MDM2—hematologic cancer	0.000185	0.000242	CbGpPWpGaD
Tyloxapol—LPL—Disease—MYC—hematologic cancer	0.000185	0.000242	CbGpPWpGaD
Tyloxapol—LPL—Disease—TGFB1—hematologic cancer	0.000184	0.000241	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MTOR—hematologic cancer	0.00018	0.000236	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CB—hematologic cancer	0.00018	0.000236	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—EP300—hematologic cancer	0.000177	0.000232	CbGpPWpGaD
Tyloxapol—LPL—Disease—KRAS—hematologic cancer	0.000171	0.000223	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN1B—hematologic cancer	0.000169	0.000221	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CASP3—hematologic cancer	0.000166	0.000217	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL2—hematologic cancer	0.000165	0.000216	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCND1—hematologic cancer	0.000161	0.000211	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JUN—hematologic cancer	0.000161	0.00021	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CA—hematologic cancer	0.000157	0.000205	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN1A—hematologic cancer	0.000156	0.000204	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTEN—hematologic cancer	0.000156	0.000204	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK8—hematologic cancer	0.000152	0.000199	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EP300—hematologic cancer	0.000148	0.000194	CbGpPWpGaD
Tyloxapol—LPL—Disease—HRAS—hematologic cancer	0.000145	0.00019	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SRC—hematologic cancer	0.000144	0.000189	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFA—hematologic cancer	0.00014	0.000184	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STAT3—hematologic cancer	0.000139	0.000182	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NRAS—hematologic cancer	0.000139	0.000182	CbGpPWpGaD
Tyloxapol—LPL—Disease—IL6—hematologic cancer	0.000139	0.000182	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK3—hematologic cancer	0.000133	0.000174	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CA—hematologic cancer	0.000131	0.000172	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MYC—hematologic cancer	0.000129	0.000169	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TGFB1—hematologic cancer	0.000129	0.000169	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT1—hematologic cancer	0.000128	0.000168	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KRAS—hematologic cancer	0.000119	0.000156	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CA—hematologic cancer	0.00011	0.000144	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKT1—hematologic cancer	0.000107	0.00014	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TP53—hematologic cancer	0.000106	0.000139	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HRAS—hematologic cancer	0.000102	0.000133	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL6—hematologic cancer	9.72e-05	0.000127	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT1—hematologic cancer	8.96e-05	0.000117	CbGpPWpGaD
